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Lack of intestinal Th17 cells in αv-tie2 mice. (A) Proportion of ROR-γT+ and FoxP3+ CD4+ cells in LP of control and αv-tie2 mice. (B and C) 
Proportion of IL-17–producing (Th17 cells) and IFN-γ–producing (Th1 cells) CD4+ T cells isolated from the LP of the small intestine and colon, 
Peyer’s patch, MLN, peripheral LN (PLN), and spleen of control and αv-tie2 mice. (B) Representative FACS data from one experiment. The plots 
are gated on CD4+ cells, and the numbers represent the percentage of CD4+ cells that stained for IL-17 or IFN-γ. (C) Mean ± SEM from at least 
3 mice/group. (D) Proportion of IL-17–producing γδ and CD8α+ T cells isolated from the LP of the colon, and IL-17–producing γδ T cells from 
indicated tissues, of control and αv-tie2 mice. (E) Expression of Il17a and Il17f measured by QRT-PCR in RNA isolated from proximal colon of 
control and αv-tie2 mice. All graphs show mean ± SEM from at least 3 mice/group. *P < 0.05.
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αv Expression by myeloid cells is required for Th17 cell differentiation. 
(A and B) Tregs and Th17 and Th1 cells in the colonic LP of SCID 
control and αv-tie2/ SCID mice 6 weeks following adoptive transfer with 
splenic CD4+ T cells from αv-tie2 (A) or wild-type control (B) mice. Data 
are from 4 littermate recipients/group. (C) Th17 and Th1 cells and Tregs 
in the colonic LP of control and αv-LysM mice (12 weeks of age). Data 
are from 4 littermates/group. In all cases, similar differences were seen 
in at least 3 independent experiments. *P < 0.05, Student’s t test.
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αv-tie2 mice are protected from EAE. 
(A) Percentage of CD4+ T cells that 
express IL-17 in spleen and LNs of 
αv-tie2 and control mice before immu-
nization (day 0) and 10 days after 
immunization with MOG peptide in 
CFA (+10). (B–D) Percentage of CD4+ 
cells (B) or IL-17– and IFN-γ–produc-
ing cells (C and D) in leukocytes iso-
lated from brain 21 days after immuni-
zation. (C) representative FACS data 
gated on CD4+ cells. (D) Percentage 
of CD4+ cells that expressed IL-17. 
(E) Progression of EAE in control and 
αv-tie2 mice. Similar data were seen 
in 3 independent experiments. (F and 
H) IL-17–producing T cells in the brain 
of αv-CD4 mice (F) and αv-LysM mice 
(H) 21 days after induction of EAE. (G 
and I) Development of EAE in con-
trol and αv-CD4 mice (G) or αv-LysM 
mice (I). Similar results were seen in 
3 (αv-tie2 data) or 2 (αv-LysM) inde-
pendent experiments. For all graphs, 
data are presented as mean ± SEM 
from at least 4 mice/group. *P < 0.05, 
Student’s t test.
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Expression of αv integrins on DCs is required for T cell responses to latent TGF-β. (A) DCs bound LAP though αv integrins. The number of control 
and αv-knockout DCs binding to untreated plates or plates coated with LAP, fibronectin (Fn), or vitronectin (Vn) is shown. Data are mean ± SD 
of 3 wells. (B) Proportion of IL-17–producing T cells generated after in vitro culture of control T cells with DCs from control and αv-tie2 mouse 
spleens in the presence of anti-CD3, IL-6, and active TGF-β (aTGF-β) or latent TGF-β (lTGF-β) (5 or 20 ng/ml). Data are from 3 separate DC 
preparations; histograms show the mean ± SEM. Similar results were seen in at least 5 independent experiments. (C and D) Production of 
IL-17A protein in culture supernatant (C) and mRNA expression of Rorc (D) in T cells stimulated as in C. (E) Contact with DCs was required for 
T cells to respond to TGF-β activated by αv. Proportion of IL-17–producing T cells generated after culture of T cells from OT2 TCR transgenic 
mice incubated with the indicated combinations of DCs from C57BL/6 and BALB/c background mice in the presence of OVA peptide, IL-6, and 
active or latent TGF-β. (F) cRGD peptides inhibited TGF-β activation by DCs. Experimental conditions were the same as in B, with T cells cultured 
with DCs in the presence of anti-CD3, IL-6, aTGF-β, lTGF-β, and cRGD peptides. Dots represent DC cultures from independent control or αv-tie2 
mice. Data are from 2 separate DC preparations from either control or αv-tie2 mice. Similar results were seen in 3 independent experiments.
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αv Blockade inhibits Th17 cell differentiation and protects from EAE in 
vivo. (A) Schematic of experiments to assess effects of cRGD on EAE 
progression. Mice were immunized (day 1) and given daily injections 
of cRGD or control peptide for 7 days, and their immune response 
was assessed at day 10, with paralysis monitored until day 21. (B) 
Percentage of LN CD4+ T cells that expressed IL-17 ten days after 
immunization (d10), or non-immunized mice (non) that also received 
cRAD/cRGD for 7 days. Each point represents an individual mouse, 
and data are combined from 2 independent experiments. *P < 0.05, 
Student’s t test (n = 9 cRAD, n = 10 cRGD). (C) Progression of EAE in 
cRGD- and cRAD-treated mice. Data are mean ± SEM from at least 5 
mice/group. *P < 0.05, Student’s t test.
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